Reduced cerebrospinal fluid BACE1 activity in multiple sclerosisMATTSSON, N; AXELSSON, M; JOHNSEN, L et al.Multiple sclerosis. 2009, Vol 15, Num 4, pp 448-454, issn 1352-4585, 7 p.Article

Possible association of HTLV-I infection and dementiaLYCKE, J; SVENNERHOLM, B; SVENNINGSSON, A et al.Acta neurologica scandinavica. 1993, Vol 88, Num 3, pp 199-203, issn 0001-6314Article

High nationwide prevalence of multiple sclerosis in SwedenAHLGREN, C; ODEN, A; LYCKE, J et al.Multiple sclerosis. 2011, Vol 17, Num 8, pp 901-908, issn 1352-4585, 8 p.Article

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosisANDERSEN, O; LYCKE, J; TOLLESSON, P. O et al.Neurology. 1996, Vol 47, Num 4, pp 895-900, issn 0028-3878Article

No evidence for spumavirus or oncovirus infection in relapsing-remitting multiple sclerosisSVENNINGSSON, A; LYCKE, J; SVENNERHOLM, B et al.Annals of neurology. 1992, Vol 32, Num 5, pp 711-714, issn 0364-5134Article

Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosisAXELSSON, M; MALMESTRÖM, C; NILSSON, S et al.Journal of neurology. 2011, Vol 258, Num 5, pp 882-888, issn 0340-5354, 7 p.Article

Brain tumours in Sweden 1996 : care and costsBLOMQVIST, P; LYCKE, J; STRANG, P et al.Journal of neurology, neurosurgery and psychiatry. 2000, Vol 69, Num 6, pp 792-798, issn 0022-3050Article

Acyclovir treatment of relapsing-remitting multiple sclerosis : a randomized, placebo-controlled, double-blind studyLYCKE, J; SVENNERHOLM, B; HJELMQUIST, E et al.Journal of neurology. 1996, Vol 243, Num 3, pp 214-224, issn 0340-5354Article

Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitopeFREDMAN, P; LYCKE, J; ANDERSEN, O et al.Journal of neurology. 1993, Vol 240, Num 6, pp 381-387, issn 0340-5354Article

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MSMALMESTROM, C; HAGHIGHI, S; ROSENGREN, L et al.Neurology. 2003, Vol 61, Num 12, pp 1720-1725, issn 0028-3878, 6 p.Article

Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritisMARTIN, C; ENBOM, M; SÖDERSTRÖM, M et al.Acta neurologica scandinavica. 1997, Vol 95, Num 5, pp 280-283, issn 0001-6314Article

Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with technetium-99m hexamethyl-propyleneamine oximeLYCKE, J; WIKKELSÖ, C; BERGH, A.-C et al.European neurology. 1993, Vol 33, Num 2, pp 163-167, issn 0014-3022Article

Incidence of MS during two fifteen-year periods in the Gothenburg region of SwedenSVENNINGSSON, A; RUNNMARKER, B; LYCKE, J et al.Acta neurologica scandinavica. 1990, Vol 82, Num 3, pp 161-168, issn 0001-6314, 8 p.Article

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsTEDEHOLM, H; LYCKE, J; MARTIN, C et al.Multiple sclerosis. 2013, Vol 19, Num 6, pp 765-774, issn 1352-4585, 10 p.Article

Glial fibrillary acidic protein in CSF of multiple sclerosis patients : relation to neurological deficitROSENGREN, L. E; LYCKE, J; ANDERSEN, O et al.Journal of the neurological sciences. 1995, Vol 133, Num 1-2, pp 61-65, issn 0022-510XArticle

Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosisLYCKE, J; ANDERSEN, O; SVENNERHOLM, B et al.Acta neurologica scandinavica. 1992, Vol 85, Num 1, pp 44-54, issn 0001-6314Article

Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptidesHORAL, P; HALL, W. W; SVENNERHOLM, B et al.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 13, pp 5754-5758, issn 0027-8424Article

Herpes simplex virus infection of the human sensory neuron: an electron microscopy studyLYCKE, E; HAMARK, B; JOHANSSON, M et al.Archives of virology. 1988, Vol 101, Num 1-2, pp 87-104, issn 0304-8608Article

High risk of MS in Iranian immigrants in Gothenburg, SwedenAHLGREN, C; LYCKE, J; ODEN, A et al.Multiple sclerosis. 2010, Vol 16, Num 9, pp 1079-1082, issn 1352-4585, 4 p.Article

A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. EditorialBECH, E; LYCKE, J; BERGSTROM, T et al.Neurology. 2002, Vol 58, Num 1, pp 7-8, issn 0028-3878, 8 p.Article

Weaning from mechanical support in a patient with acute heart failure and multiple sclerosisKJELLMAN, U. W; HALLGREN, P; BERGH, C.-H et al.The Annals of thoracic surgery. 2000, Vol 69, Num 2, pp 628-630, issn 0003-4975Article

Human spumaretrovirus antibody reactivity in multiple sclerosisLYCKE, J; SVENNERHOLM, B; SVENNINGSSON, A et al.Journal of neurology. 1994, Vol 241, Num 4, pp 204-209, issn 0340-5354Conference Paper

Acyclovir concentrations in serum and cerebrospinal fluid at steady stateLYCKE, J; ANDERSEN, O; SVENNERHOLM, B et al.Journal of antimicrobial chemotherapy (Print). 1989, Vol 24, Num 6, pp 947-954, issn 0305-7453Article

Neurofilament protein in cerebrospinal fluid : a potential marker of activity in multiple sclerosisLYCKE, J. N; KARLSSON, J.-E; ANDERSEN, O et al.Journal of neurology, neurosurgery and psychiatry. 1998, Vol 64, Num 3, pp 402-404, issn 0022-3050Article